NCT05103254View on ClinicalTrials.gov

Bempedoic Acid Pregnancy Surveillance Program

RecruitingOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

May 31, 2032

Study Completion Date

May 31, 2032

Conditions
PregnancyHyperlipidemias
Interventions
DRUG

Bempedoic Acid

Bempedoic Acid 180 MG

DRUG

Bempedoic Acid / Ezetimibe

Bempedoic Acid 180 MG / Ezetimibe 10 MG

Trial Locations (1)

27560

RECRUITING

Evidera, PPD business unit, Morrisville

Sponsors
All Listed Sponsors
lead

Esperion Therapeutics, Inc.

INDUSTRY